EP0309555A4 - Immunogenic polypeptide and method for purifying it. - Google Patents

Immunogenic polypeptide and method for purifying it.

Info

Publication number
EP0309555A4
EP0309555A4 EP19880903724 EP88903724A EP0309555A4 EP 0309555 A4 EP0309555 A4 EP 0309555A4 EP 19880903724 EP19880903724 EP 19880903724 EP 88903724 A EP88903724 A EP 88903724A EP 0309555 A4 EP0309555 A4 EP 0309555A4
Authority
EP
European Patent Office
Prior art keywords
purifying
immunogenic polypeptide
immunogenic
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19880903724
Other languages
German (de)
French (fr)
Other versions
EP0309555A1 (en
Inventor
Victor Nussenzweig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University NYU
Original Assignee
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York University NYU filed Critical New York University NYU
Publication of EP0309555A1 publication Critical patent/EP0309555A1/en
Publication of EP0309555A4 publication Critical patent/EP0309555A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP19880903724 1987-03-30 1988-03-30 Immunogenic polypeptide and method for purifying it. Withdrawn EP0309555A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3232687A 1987-03-30 1987-03-30
US32326 1987-03-30

Publications (2)

Publication Number Publication Date
EP0309555A1 EP0309555A1 (en) 1989-04-05
EP0309555A4 true EP0309555A4 (en) 1990-04-10

Family

ID=21864341

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19880903724 Withdrawn EP0309555A4 (en) 1987-03-30 1988-03-30 Immunogenic polypeptide and method for purifying it.

Country Status (9)

Country Link
EP (1) EP0309555A4 (en)
JP (1) JPH01503514A (en)
AU (1) AU617668B2 (en)
ES (1) ES2009587A6 (en)
IL (1) IL85905A0 (en)
NZ (1) NZ224086A (en)
PT (2) PT87137B (en)
WO (1) WO1988007546A1 (en)
ZA (1) ZA882272B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
SE8904100D0 (en) * 1989-12-05 1989-12-05 Astra Ab NEW ANALYSIS METHOD
NZ233255A (en) * 1989-04-11 1993-02-25 Chiron Corp Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
US5095093A (en) * 1990-11-06 1992-03-10 The United States Of America As Represented By The Secretary Of The Navy Protective four amino acid epitope against Plasmodium vivax malaria
WO1993011157A1 (en) * 1991-11-27 1993-06-10 The Council Of The Queensland Institute Of Medical Research MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
WO1986001721A1 (en) * 1984-09-12 1986-03-27 New York University Cross-reactive and protective epitopes of circumsporozoite proteins
WO1987000533A1 (en) * 1985-07-12 1987-01-29 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
EP0252588A2 (en) * 1986-05-12 1988-01-13 Smithkline Beecham Corporation Process for the isolation and purification of P. falciparum CS protein expressed in recombinant E. coli, and its use as a vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
WO1986001721A1 (en) * 1984-09-12 1986-03-27 New York University Cross-reactive and protective epitopes of circumsporozoite proteins
WO1987000533A1 (en) * 1985-07-12 1987-01-29 New York University Immunogenic peptide antigen corresponding to plasmodium vivax circumsporozoite protein
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene
EP0252588A2 (en) * 1986-05-12 1988-01-13 Smithkline Beecham Corporation Process for the isolation and purification of P. falciparum CS protein expressed in recombinant E. coli, and its use as a vaccine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8807546A1 *

Also Published As

Publication number Publication date
AU1593688A (en) 1988-11-02
NZ224086A (en) 1991-02-26
PT87332A (en) 1988-05-01
PT87332B (en) 1992-07-31
IL85905A0 (en) 1988-09-30
ES2009587A6 (en) 1989-10-01
AU617668B2 (en) 1991-12-05
PT87137B (en) 1992-07-31
ZA882272B (en) 1988-09-22
JPH01503514A (en) 1989-11-30
PT87137A (en) 1988-04-01
WO1988007546A1 (en) 1988-10-06
EP0309555A1 (en) 1989-04-05

Similar Documents

Publication Publication Date Title
GB8721424D0 (en) Recombinant expression method
EP0289050A3 (en) Interleave sequence method
GB2215635B (en) Emulsification method
EG19250A (en) Method for purifying aminomethylenephosphonics acids.
GB2189290B (en) Connecting means and method
AR244495A1 (en) Fumigation method
EP0240843A3 (en) Photosensitive composite, method for preparing it and use thereof
EP0274496A4 (en) Composition and method for immunological castration and spaying.
EP0238656A4 (en) Method for administering vaccines and compositions therefor.
EP0314190A3 (en) Sequence control system and its method
EP0309555A4 (en) Immunogenic polypeptide and method for purifying it.
IL88321A0 (en) Sialocylglycerolipids and method for preparing same
EP0270497A3 (en) Dough-rolling method
IL85893A0 (en) Method for stabilizing proteins
GB8703605D0 (en) Combustion method & system
IL92033A0 (en) Catalyst and method for the preparation thereof
ZA886915B (en) 4-azasaccharines,4-aza-dihydro-or-tetrahydro-saccharines and processes for the preparation thereof
GB2204893B (en) Structural unit and method for the manufacture thereof
EP0434836A4 (en) Method for purifying teneicine
GB2194544B (en) Imidopolysiloxanes and method for making
EP0288901A3 (en) Recombinant human glutathione peroxidase, process for preparing the same and dna coding the same
EP0266414A4 (en) Method for preparing contact-inhibitory factor.
IE872149L (en) Hair-cleaning method and composition.
EG17874A (en) Method for eliminating or reducing the dessire for smoking
BG43441A1 (en) 2- hydroxylamino- 4, 5- dimetoxybenamide and method for its preparation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19890116

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19900410

17Q First examination report despatched

Effective date: 19920902

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19940728